Ramón Planas

Active 1983–2023

Also published as
Ramon Planas
84
Papers
26,760
Citations
76
h-index
83
i10-index

Citations

Citations per year for Ramón Planas1979: 2 citations1983: 1 citations1984: 3 citations1985: 10 citations1986: 8 citations1987: 6 citations1988: 12 citations1989: 4 citations1990: 10 citations1991: 23 citations1992: 19 citations1993: 19 citations1994: 34 citations1995: 30 citations1996: 27 citations1997: 36 citations1998: 47 citations1999: 41 citations2000: 74 citations2001: 93 citations2002: 81 citations2003: 143 citations2004: 157 citations2005: 156 citations2006: 167 citations2007: 179 citations2008: 240 citations2009: 260 citations2010: 258 citations2011: 237 citations2012: 245 citations2013: 181 citations2014: 240 citations2015: 254 citations2016: 191 citations2017: 220 citations2018: 174 citations2019: 536 citations2020: 506 citations2021: 499 citations2022: 338 citations2023: 282 citations2024: 346 citations2025: 144 citations2026: 15 citations1980–1982: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,571 citing papers, 21.7% of this breakdownSpain: 723 citing papers, 10% of this breakdownItaly: 560 citing papers, 7.7% of this breakdownChina: 525 citing papers, 7.2% of this breakdownUnited Kingdom: 482 citing papers, 6.6% of this breakdownGermany: 381 citing papers, 5.3% of this breakdownFrance: 350 citing papers, 4.8% of this breakdownCanada: 246 citing papers, 3.4% of this breakdownJapan: 196 citing papers, 2.7% of this breakdownSwitzerland: 184 citing papers, 2.5% of this breakdownAustria: 154 citing papers, 2.1% of this breakdownSouth Korea: 145 citing papers, 2% of this breakdown
0%21.7%Other 24%

Fields

  • Medicine82.5%
  • Biochemistry, Genetics and Molecular Biology6.5%
  • Pharmacology, Toxicology and Pharmaceutics5%
  • Engineering3.5%
  • Immunology and Microbiology0.6%
  • Nursing0.4%
  • Other1.5%

Topics

  • Liver Disease and Transplantation15%
  • Liver Disease Diagnosis and Treatment13.7%
  • Hepatocellular Carcinoma Treatment and Prognosis7.5%
  • Organ Transplantation Techniques and Outcomes5.3%
  • Drug-Induced Hepatotoxicity and Protection3.3%
  • Hepatitis C virus research3%
  • Other52.2%

Coauthors

All papers

Open in search
  1. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

    Authors: , , , , , , , , , , , - The Lancet 2002 cited by 3,500

  2. Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated Cirrhosis

    Authors: , , , , , , , , , , , - Gastroenterology 2007 cited by 1,175

  3. High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2018 cited by 281

  4. Oral Bile Acids Reduce Bacterial Overgrowth, Bacterial Translocation, and Endotoxemia in Cirrhotic Rats

    Authors: , , , , , , , , , , - Hepatology 2003 cited by 320

  5. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Blanca López‐Ibor, Ricardo López Almaraz, José Antonio Salinas, Bárbara Torres, F Hernández, Jose Javier Uriz, Monique Fabrè, Julià Blanco, Claudia Paris, Viera Bajčiová, Geneviève Laureys, Helena Masnou, Ariadna Clos, Cristina Beléndez, Catherine Guettier, Lauro Sumoy, Ramón Planas, Mireia Jordà, Lara Nonell, Piotr Czauderna, Bruce Morland, Daniela Sia, Bojan Losic, Marie Annick Buendia, Maria‐Rosa Sarrias, Josep M. Llovet, Carolina Armengol - Journal of Hepatology 2020 cited by 147

  6. The Management of Ascites in Cirrhosis: Report on the Consensus Conference of the International Ascites Club

    Authors: , , , , , , , , , , , , - Hepatology 2003 cited by 970

  7. Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ángela Puente, Joaquín de la Peña, José Mera Calviño, Laura Rivas Moral, Oana Pavel, Edilmar Alvarado, Alba Ardèvol, Anna Girbau, Alba Cachero, Joan Albert Arnáiz, Annalisa Berzigotti, Judit Pich, José Ríos, Rosa Saenz, Laura Millán, Helena Beleta, Núria Ramos - Gastroenterology 2016 cited by 328

  8. Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis

    Authors: , , , , , , , , , , , - New England Journal of Medicine 1999 cited by 1,643

  9. Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2005 cited by 997

  10. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis

    Authors: , , , , , , , , , , , - Journal of Hepatology 2009 cited by 407

  11. Block recursive LU preconditioners for the thermally coupled incompressible inductionless MHD problem

    Authors: , , - Journal of Computational Physics, J. Comput. Phys. 2014 cited by 58

  12. Electromagnetic Tomography for Detection, Differentiation, and Monitoring of Brain Stroke: A Virtual Data and Human Head Phantom Study

    Authors: , , , , - IEEE Antennas and Propagation Magazine 2017 cited by 166

  13. Approximation of the inductionless MHD problem using a stabilized finite element method

    Authors: , , - Journal of Computational Physics, J. Comput. Phys. 2011 cited by 70

  14. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document

    Authors: , , , , , , - Journal of Hepatology 2000 cited by 1,064

  15. Primary Prophylaxis of Spontaneous Bacterial Peritonitis Delays Hepatorenal Syndrome and Improves Survival in Cirrhosis

    Authors: , , , , , , , , , , , , - Gastroenterology 2007 cited by 715

  16. Natural History of Patients Hospitalized for Management of Cirrhotic Ascites

    Authors: , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2006 cited by 398

  17. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , - Hepatology 1990 cited by 636

  18. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis

    Authors: , , , , , , , , , - Gastroenterology 2002 cited by 541

  19. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality

    Authors: , , , , , , , , - Hepatology 1998 cited by 430

  20. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis

    Authors: , , , , , , , , , , , , , - Gastroenterology 1988 cited by 646

  21. Serum and ascitic fluid bacterial DNA: A new independent prognostic factor in noninfected patients with cirrhosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2008 cited by 165

  22. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial

    Authors: , , , , , , , , , - Journal of Hepatology 1998 cited by 327

  23. Comparison of Paracentesis and Diuretics in the Treatment of Cirrhotics With Tense Ascites

    Authors: , , , , , , , , , , , , - Gastroenterology 1987 cited by 471

  24. Norfloxacin vs Ceftriaxone in the Prophylaxis of Infections in Patients With Advanced Cirrhosis and Hemorrhage

    Authors: , , , , , , , , - Gastroenterology 2006 cited by 454